The first and only agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsy,* LYMPHOSEEK provides accurate and precise lymph node identification in patients with solid tumors.
Mechanism of Action
Clinical Efficacy: Solid Tumors
Review this section for more information on how to use LYMPHOSEEK in your patients to assist in the localization of lymph nodes draining a primary tumor site.
Dosing and Administration
Cardinal Health Nuclear Pharmacy Services Resources
U.S. Patent Nos.: 6,409,990; 8,545,808; 9,439,985. Other patents pending.